Healthtech Startups

Sirnaomics is an RNA therapeutics company developing RNA interference (RNAi) drugs using its proprietary PNP (Peptide Nanoparticle) delivery platform for extra-hepatic delivery and its GalAHead technology for controlling therapeutic duration. Its pipeline spans oncology, regenerative and aesthetic medicine, and cardiovascular and metabolic diseases.

0 investors

0 investors

Sisu Pharma develops therapeutics targeting Heat Shock Factor 1 (HSF1), using its HI-LiTe platform to create selective HSF1 degraders for oncology and HSF1 activators for neurodegenerative diseases. Its compounds are aimed at therapy-resistant cancers and other difficult-to-treat diseases.

0 investors

0 investors

0 investors

0 investors

0 investors

Skelo Wear develops protective wearable gear designed to reduce hand and wrist injuries for athletes, with a focus on sports such as football. The company markets performance and protection equipment for competitive athletes.

0 investors

SkinIO offers AI-powered skin imaging combined with connections to dermatology care to enable early detection of skin cancer. The company focuses on making skin cancer screening accessible, including through employer relationships, in the United States.

0 investors

SkinJect develops a dissolvable microneedle patch delivery system to treat non-melanoma skin cancers such as basal cell carcinoma by stimulating an immune response against the disease. The device combines FDA-approved microneedles and chemotherapy cargo for topical skin cancer treatment.

0 investors

Skuvent is a field inventory operations platform for medical device companies that replaces spreadsheets and manual coordination with structured workflows and real-time tracking of devices, loaner sets, and consignment inventory from warehouse to procedure room. It serves field reps, operations teams, and executives, and integrates with ERP, CRM, and UDI-compliant tracking systems.

0 investors

0 investors

0 investors

0 investors

Buzz is a HIPAA-secure clinical communication and collaboration platform that consolidates messaging, document sharing, e-signatures, video, and EMR integration for distributed healthcare teams. It serves clinics, home health, hospice, and post-acute care providers seeking compliant care coordination workflows.

0 investors

0 investors

0 investors

SLAM BioTherapeutics is a preclinical-stage biotech developing first-in-class antibody-drug conjugates (ADCs) and bispecific monoclonal antibodies targeting the SLAM family of immune receptors (notably CD84/SLAMF5) for blood cancers such as MDS, AML, CTCL, and follicular lymphoma. Its lead asset SLM124 is planned to enter Phase 1 clinical trials in 2026, serving patients with hard-to-treat hematologic malignancies.

0 investors

0 investors

SleepRes develops Kairos Positive Airway Pressure (KPAP), a pressure-delivery approach for treating sleep apnea, delivered through Kricket, an FDA-approved PAP device. The company serves sleep apnea patients and healthcare providers, aiming to improve therapy adherence compared to conventional CPAP.

0 investors

Slipstream Solutions develops medical technology to address fluid stasis and support recovery and rehabilitation for caregivers, trainers, and patients, with a focus on underserved populations.

0 investors

0 investors

0 investors

Smart Infusion Therapy Services provides infusion treatments in an outpatient setting as an alternative to hospital-based infusions, working with medical providers to deliver the care. It serves patients, including those with chronic conditions, and emphasizes lower costs compared to hospital outpatient settings.

0 investors